Markus Raderer

22PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologySolid tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 07, 2026
Long-term complete remission following treatment with polatuzumab vedotin, rituximab, and bendamustine in a patient with mantle cell lymphoma relapsing after CAR-T cell therapy: a case report.

|Jun 02, 2026
B7-H3 (CD276) as a candidate therapeutic target in medullary thyroid cancer.

|Dec 03, 2024
Clinicopathological Characteristics of Extranodal Marginal Zone Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT-Lymphoma) of the Intestine: A Single Center Analysis.

Oskar Steinbrecher, Barbara Kiesewetter, Werner Dolak

|Jun 24, 2024
Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study.

E Baudin, J Capdevila, D Hörsch

|Mar 26, 2024
From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms.

Philipp Melhorn, Peter Mazal, Ladislaia Wolff

|Jan 12, 2024
Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms.

Philipp Melhorn, Peter Mazal, Ladislaia Wolff

Pageof 4

Frequent Collaborators

13 joint publications

Barbara Kiesewetter

4 joint publications

Philipp Melhorn

1 joint publications

G Rendl

1 joint publications

B Sipos